0001185348-24-000052.txt : 20241108 0001185348-24-000052.hdr.sgml : 20241108 20241108170546 ACCESSION NUMBER: 0001185348-24-000052 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 74 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241108 DATE AS OF CHANGE: 20241108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PRA GROUP INC CENTRAL INDEX KEY: 0001185348 STANDARD INDUSTRIAL CLASSIFICATION: SHORT-TERM BUSINESS CREDIT INSTITUTIONS [6153] ORGANIZATION NAME: 02 Finance IRS NUMBER: 753078675 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-50058 FILM NUMBER: 241441676 BUSINESS ADDRESS: STREET 1: 120 CORPORATE BLVD STE 100 CITY: NORFOLK STATE: VA ZIP: 23502 BUSINESS PHONE: 7575199300X3023 MAIL ADDRESS: STREET 1: 120 CORPORATE BLVD STE 100 CITY: NORFOLK STATE: VA ZIP: 23502 FORMER COMPANY: FORMER CONFORMED NAME: PORTFOLIO RECOVERY ASSOCIATES INC DATE OF NAME CHANGE: 20020903 10-Q 1 praa-20240930.htm 10-Q praa-20240930
false2024Q3000118534812/31http://fasb.org/us-gaap/2024#OtherAssetshttp://fasb.org/us-gaap/2024#OtherAssetshttp://fasb.org/us-gaap/2024#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherAssetshttp://fasb.org/us-gaap/2024#OtherAssetshttp://fasb.org/us-gaap/2024#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesCurrentxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureiso4217:EURiso4217:SEK00011853482024-01-012024-09-3000011853482024-10-3100011853482024-09-3000011853482023-12-3100011853482024-07-012024-09-3000011853482023-07-012023-09-3000011853482023-01-012023-09-300001185348us-gaap:CommonStockMember2023-12-310001185348us-gaap:AdditionalPaidInCapitalMember2023-12-310001185348us-gaap:RetainedEarningsMember2023-12-310001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001185348us-gaap:NoncontrollingInterestMember2023-12-310001185348us-gaap:RetainedEarningsMember2024-01-012024-03-310001185348us-gaap:NoncontrollingInterestMember2024-01-012024-03-3100011853482024-01-012024-03-310001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001185348us-gaap:CommonStockMember2024-01-012024-03-310001185348us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001185348us-gaap:CommonStockMember2024-03-310001185348us-gaap:AdditionalPaidInCapitalMember2024-03-310001185348us-gaap:RetainedEarningsMember2024-03-310001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001185348us-gaap:NoncontrollingInterestMember2024-03-3100011853482024-03-310001185348us-gaap:RetainedEarningsMember2024-04-012024-06-300001185348us-gaap:NoncontrollingInterestMember2024-04-012024-06-3000011853482024-04-012024-06-300001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-04-012024-06-300001185348us-gaap:CommonStockMember2024-04-012024-06-300001185348us-gaap:AdditionalPaidInCapitalMember2024-04-012024-06-300001185348us-gaap:CommonStockMember2024-06-300001185348us-gaap:AdditionalPaidInCapitalMember2024-06-300001185348us-gaap:RetainedEarningsMember2024-06-300001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001185348us-gaap:NoncontrollingInterestMember2024-06-3000011853482024-06-300001185348us-gaap:RetainedEarningsMember2024-07-012024-09-300001185348us-gaap:NoncontrollingInterestMember2024-07-012024-09-300001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001185348us-gaap:CommonStockMember2024-07-012024-09-300001185348us-gaap:AdditionalPaidInCapitalMember2024-07-012024-09-300001185348us-gaap:CommonStockMember2024-09-300001185348us-gaap:AdditionalPaidInCapitalMember2024-09-300001185348us-gaap:RetainedEarningsMember2024-09-300001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001185348us-gaap:NoncontrollingInterestMember2024-09-300001185348us-gaap:CommonStockMember2022-12-310001185348us-gaap:AdditionalPaidInCapitalMember2022-12-310001185348us-gaap:RetainedEarningsMember2022-12-310001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001185348us-gaap:NoncontrollingInterestMember2022-12-3100011853482022-12-310001185348us-gaap:RetainedEarningsMember2023-01-012023-03-310001185348us-gaap:NoncontrollingInterestMember2023-01-012023-03-3100011853482023-01-012023-03-310001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-03-310001185348us-gaap:CommonStockMember2023-01-012023-03-310001185348us-gaap:AdditionalPaidInCapitalMember2023-01-012023-03-310001185348us-gaap:CommonStockMember2023-03-310001185348us-gaap:AdditionalPaidInCapitalMember2023-03-310001185348us-gaap:RetainedEarningsMember2023-03-310001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-03-310001185348us-gaap:NoncontrollingInterestMember2023-03-3100011853482023-03-310001185348us-gaap:RetainedEarningsMember2023-04-012023-06-300001185348us-gaap:NoncontrollingInterestMember2023-04-012023-06-3000011853482023-04-012023-06-300001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-012023-06-300001185348us-gaap:CommonStockMember2023-04-012023-06-300001185348us-gaap:AdditionalPaidInCapitalMember2023-04-012023-06-300001185348us-gaap:CommonStockMember2023-06-300001185348us-gaap:AdditionalPaidInCapitalMember2023-06-300001185348us-gaap:RetainedEarningsMember2023-06-300001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001185348us-gaap:NoncontrollingInterestMember2023-06-3000011853482023-06-300001185348us-gaap:RetainedEarningsMember2023-07-012023-09-300001185348us-gaap:NoncontrollingInterestMember2023-07-012023-09-300001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001185348us-gaap:CommonStockMember2023-07-012023-09-300001185348us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-300001185348us-gaap:CommonStockMember2023-09-300001185348us-gaap:AdditionalPaidInCapitalMember2023-09-300001185348us-gaap:RetainedEarningsMember2023-09-300001185348us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001185348us-gaap:NoncontrollingInterestMember2023-09-3000011853482023-09-300001185348praa:A2030NotesMember2024-01-012024-09-300001185348praa:A2030NotesMember2023-01-012023-09-300001185348praa:A2028NotesMember2024-01-012024-09-300001185348praa:A2028NotesMember2023-01-012023-09-300001185348praa:A2025NotesMember2024-01-012024-09-300001185348praa:A2025NotesMember2023-01-012023-09-300001185348praa:NoteDue2023Member2024-01-012024-09-300001185348praa:NoteDue2023Member2023-01-012023-09-300001185348praa:CorePortfolioSegmentMember2024-06-300001185348praa:InsolvencyPortfolioSegmentMember2024-06-300001185348praa:CorePortfolioSegmentMember2023-06-300001185348praa:InsolvencyPortfolioSegmentMember2023-06-300001185348praa:CorePortfolioSegmentMember2024-07-012024-09-300001185348praa:InsolvencyPortfolioSegmentMember2024-07-012024-09-300001185348praa:CorePortfolioSegmentMember2023-07-012023-09-300001185348praa:InsolvencyPortfolioSegmentMember2023-07-012023-09-300001185348praa:CorePortfolioSegmentMember2024-09-300001185348praa:InsolvencyPortfolioSegmentMember2024-09-300001185348praa:CorePortfolioSegmentMember2023-09-300001185348praa:InsolvencyPortfolioSegmentMember2023-09-300001185348praa:CorePortfolioSegmentMember2023-12-310001185348praa:InsolvencyPortfolioSegmentMember2023-12-310001185348praa:CorePortfolioSegmentMember2022-12-310001185348praa:InsolvencyPortfolioSegmentMember2022-12-310001185348praa:CorePortfolioSegmentMember2024-01-012024-09-300001185348praa:InsolvencyPortfolioSegmentMember2024-01-012024-09-300001185348praa:CorePortfolioSegmentMember2023-01-012023-09-300001185348praa:InsolvencyPortfolioSegmentMember2023-01-012023-09-300001185348us-gaap:PrivateEquityFundsMember2024-09-300001185348us-gaap:PrivateEquityFundsMember2023-12-310001185348praa:GovernmentBondsandFixedIncomeFundsMember2024-09-300001185348praa:GovernmentBondsandFixedIncomeFundsMember2023-12-310001185348praa:RCBInvestimentosSARCBMemberpraa:RCBInvestimentosS.A.Member2024-09-300001185348praa:AmericasRevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-300001185348praa:AmericasRevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2023-12-310001185348praa:UKCreditAgreementMemberpraa:UKRevolvingCreditMemberus-gaap:LineOfCreditMember2024-09-300001185348praa:UKCreditAgreementMemberpraa:UKRevolvingCreditMemberus-gaap:LineOfCreditMember2023-12-310001185348praa:EuropeanRevolvingFacilityandTermLoanMemberpraa:EuropeRevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2024-09-300001185348praa:EuropeanRevolvingFacilityandTermLoanMemberpraa:EuropeRevolvingCreditFacilityMemberus-gaap:LineOfCreditMember2023-12-310001185348praa:NorthAmericanCreditAgreementMemberus-gaap:LoansPayableMember2024-09-300001185348praa:NorthAmericanCreditAgreementMemberus-gaap:LoansPayableMember2023-12-310001185348praa:LineOfCreditAndLoansPayableMember2024-09-300001185348praa:LineOfCreditAndLoansPayableMember2023-12-310001185348praa:A2025NotesMemberus-gaap:SeniorNotesMember2024-09-300001185348praa:A2025NotesMemberus-gaap:SeniorNotesMember2023-12-310001185348praa:A2028NotesMemberus-gaap:SeniorNotesMember2024-09-300001185348praa:A2028NotesMemberus-gaap:SeniorNotesMember2023-12-310001185348praa:A2029NotesMemberus-gaap:SeniorNotesMember2024-09-300001185348praa:A2029NotesMemberus-gaap:SeniorNotesMember2023-12-310001185348praa:A2030NotesMemberus-gaap:SeniorNotesMember2024-09-300001185348praa:A2030NotesMemberus-gaap:SeniorNotesMember2023-12-310001185348us-gaap:SeniorNotesMember2024-09-300001185348us-gaap:SeniorNotesMember2023-12-310001185348praa:NorthAmericanCreditAgreementMember2024-09-300001185348praa:NorthAmericanCreditAgreementMemberus-gaap:RevolvingCreditFacilityMember2024-09-300001185348praa:NorthAmericanCreditAgreementMemberpraa:CanadianRevolvingCreditFacilityMember2024-09-300001185348praa:UKCreditAgreementMemberpraa:UKRevolvingCreditMemberus-gaap:LineOfCreditMemberus-gaap:SubsequentEventMember2024-10-300001185348praa:EuropeanRevolvingFacilityandTermLoanMemberpraa:EuropeRevolvingCreditFacilityMembersrt:MaximumMember2024-09-300001185348praa:NorthAmericanCreditAgreementMember2024-07-012024-09-300001185348us-gaap:SeniorNotesMember2024-09-032024-09-030001185348praa:A2030NotesMemberus-gaap:SeniorNotesMember2024-05-200001185348praa:A2030NotesMemberus-gaap:SeniorNotesMemberpraa:OnOrBeforeJune12026Member2024-05-202024-05-200001185348praa:A2030NotesMemberus-gaap:SeniorNotesMemberpraa:OnOrAfterJune12026Member2024-05-202024-05-200001185348praa:A2030NotesMemberus-gaap:SeniorNotesMemberpraa:June12027ToMay312028Member2024-05-202024-05-200001185348praa:A2030NotesMemberus-gaap:SeniorNotesMemberpraa:June12028AndThereafterMember2024-05-202024-05-200001185348praa:ChangeOfControlEventMemberpraa:A2030NotesMemberus-gaap:SeniorNotesMember2024-05-202024-05-200001185348praa:CertainAssetSaleEventsMemberpraa:A2030NotesMemberus-gaap:SeniorNotesMember2024-05-202024-05-200001185348us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2024-09-300001185348us-gaap:InterestRateContractMemberus-gaap:DesignatedAsHedgingInstrumentMember2023-12-310001185348us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2024-09-300001185348us-gaap:ForeignExchangeContractMemberus-gaap:NondesignatedMember2023-12-310001185348srt:MinimumMember2024-07-012024-09-300001185348srt:MaximumMember2024-07-012024-09-300001185348us-gaap:InterestRateContractMember2024-07-012024-09-300001185348us-gaap:InterestRateContractMember2023-07-012023-09-300001185348us-gaap:InterestRateContractMember2024-01-012024-09-300001185348us-gaap:InterestRateContractMember2023-01-012023-09-300001185348us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMember2024-07-012024-09-300001185348us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMember2023-07-012023-09-300001185348us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMember2024-01-012024-09-300001185348us-gaap:InterestExpenseMemberus-gaap:InterestRateContractMember2023-01-012023-09-300001185348us-gaap:ForeignCurrencyGainLossMemberus-gaap:ForeignExchangeContractMember2024-07-012024-09-300001185348us-gaap:ForeignCurrencyGainLossMemberus-gaap:ForeignExchangeContractMember2023-07-012023-09-300001185348us-gaap:ForeignCurrencyGainLossMemberus-gaap:ForeignExchangeContractMember2024-01-012024-09-300001185348us-gaap:ForeignCurrencyGainLossMemberus-gaap:ForeignExchangeContractMember2023-01-012023-09-300001185348us-gaap:InterestExpenseMemberus-gaap:ForeignExchangeContractMember2024-07-012024-09-300001185348us-gaap:InterestExpenseMemberus-gaap:ForeignExchangeContractMember2023-07-012023-09-300001185348us-gaap:InterestExpenseMemberus-gaap:ForeignExchangeContractMember2024-01-012024-09-300001185348us-gaap:InterestExpenseMemberus-gaap:ForeignExchangeContractMember2023-01-012023-09-300001185348us-gaap:CarryingReportedAmountFairValueDisclosureMember2024-09-300001185348us-gaap:EstimateOfFairValueFairValueDisclosureMember2024-09-300001185348us-gaap:CarryingReportedAmountFairValueDisclosureMember2023-12-310001185348us-gaap:EstimateOfFairValueFairValueDisclosureMember2023-12-310001185348us-gaap:FairValueInputsLevel1Memberpraa:GovernmentBondsMember2024-09-300001185348us-gaap:FairValueInputsLevel2Memberpraa:GovernmentBondsMember2024-09-300001185348us-gaap:FairValueInputsLevel3Memberpraa:GovernmentBondsMember2024-09-300001185348praa:GovernmentBondsMember2024-09-300001185348us-gaap:FairValueInputsLevel1Member2024-09-300001185348us-gaap:FairValueInputsLevel2Member2024-09-300001185348us-gaap:FairValueInputsLevel3Member2024-09-300001185348us-gaap:FairValueInputsLevel1Memberpraa:GovernmentBondsMember2023-12-310001185348us-gaap:FairValueInputsLevel2Memberpraa:GovernmentBondsMember2023-12-310001185348us-gaap:FairValueInputsLevel3Memberpraa:GovernmentBondsMember2023-12-310001185348praa:GovernmentBondsMember2023-12-310001185348us-gaap:FairValueInputsLevel1Member2023-12-310001185348us-gaap:FairValueInputsLevel2Member2023-12-310001185348us-gaap:FairValueInputsLevel3Member2023-12-310001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2024-01-012024-09-300001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMemberus-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-300001185348us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-06-300001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-06-300001185348us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-06-300001185348us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-06-300001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-06-300001185348us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-06-300001185348us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-07-012024-09-300001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-07-012024-09-300001185348us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-07-012024-09-300001185348us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-07-012023-09-300001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-07-012023-09-300001185348us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-07-012023-09-300001185348us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-09-300001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-09-300001185348us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-09-300001185348us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-09-300001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-09-300001185348us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-09-300001185348us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-12-310001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-12-310001185348us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-12-310001185348us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2022-12-310001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2022-12-310001185348us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2022-12-310001185348us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-09-300001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2024-01-012024-09-300001185348us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2024-01-012024-09-300001185348us-gaap:AccumulatedNetInvestmentGainLossIncludingPortionAttributableToNoncontrollingInterestMember2023-01-012023-09-300001185348us-gaap:AccumulatedGainLossCashFlowHedgeIncludingNoncontrollingInterestMember2023-01-012023-09-300001185348us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember2023-01-012023-09-300001185348praa:NorthAmericanCreditAgreementMemberus-gaap:LoansPayableMemberus-gaap:SubsequentEventMember2024-10-280001185348praa:NorthAmericanCreditAgreementMemberus-gaap:SubsequentEventMember2024-10-280001185348praa:NorthAmericanCreditAgreementMemberus-gaap:RevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2024-10-280001185348praa:NorthAmericanCreditAgreementMemberpraa:CanadianRevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2024-10-280001185348praa:EuropeanRevolvingFacilityandTermLoanMemberpraa:EuropeRevolvingCreditFacilityMemberus-gaap:SubsequentEventMember2024-10-280001185348praa:EuropeanRevolvingFacilityandTermLoanMemberpraa:EuropeRevolvingCreditFacilityMember2024-09-30

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended September 30, 2024
Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from ________ to ________
Commission File Number: 000-50058
PRA Group, Inc.
(Exact name of registrant as specified in its charter)
Delaware75-3078675
(State or other jurisdiction of incorporation or organization)(I.R.S. Employer Identification No.)

120 Corporate Boulevard
Norfolk, Virginia 23502
(Address of principal executive offices)

(888) 772-7326
(Registrant's Telephone No., including area code)

Not Applicable
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par value per sharePRAANASDAQ Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  þ   No  ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  þ   No  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer  þ   Accelerated filer  ¨   Non-accelerated filer  ¨   Smaller reporting company   Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes     No  þ

The number of shares of the registrant's common stock outstanding as of October 31, 2024 was 39,426,698.



Table of Contents

Item 1.
Item 2.
Item 3.
Item 4.
Item 1.
Item 1A.
Item 2.
Item 3.
Item 4.
Item 5.
Item 6.
Signatures
2


Part I. Financial Information
Item 1. Financial Statements (Unaudited)
PRA Group, Inc.
Consolidated Balance Sheets
September 30, 2024 and December 31, 2023
(Amounts in thousands)
(unaudited)
September 30,
2024
December 31,
2023
Assets
Cash and cash equivalents$141,135 $112,528 
Investments61,322 72,404 
Finance receivables, net4,064,467 3,656,598 
Income taxes receivable33,368 27,713 
Deferred tax assets, net88,260 74,694 
Right-of-use assets40,831 45,877 
Property and equipment, net31,835 36,450 
Goodwill423,011 431,564 
Other assets51,841 67,526 
Total assets$4,936,070 $4,525,354 
Liabilities and Equity
Liabilities:
Accounts payable$8,176 $6,325 
Accrued expenses108,926 131,893 
Income taxes payable27,501 17,912 
Deferred tax liabilities, net19,881 17,051 
Lease liabilities45,222 50,300 
Interest-bearing deposits128,594 115,589 
Borrowings3,296,172 2,914,270 
Other liabilities19,806 32,638 
Total liabilities3,654,278 3,285,978 
Equity:
Preferred stock, $0.01 par value, 2,000 shares authorized, no shares issued and outstanding
  
Common stock, $0.01 par value; 100,000 shares authorized, 39,426 shares issued and outstanding as of September 30, 2024; 100,000 shares authorized, 39,247 shares issued and outstanding as of December 31, 2023
394 392 
Additional paid-in capital15,415 7,071 
Retained earnings1,541,693 1,489,548 
Accumulated other comprehensive loss(338,620)(329,899)
Total stockholders' equity - PRA Group, Inc.1,218,882 1,167,112 
Noncontrolling interests62,910 72,264 
Total equity1,281,792 1,239,376 
Total liabilities and equity$4,936,070 $4,525,354 
The accompanying notes are an integral part of these Consolidated Financial Statements.
3


PRA Group, Inc.
Consolidated Income Statements
For the Three and Nine Months Ended September 30, 2024 and 2023
(Amounts in thousands, except per share amounts)
(unaudited)

Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Revenues:
Portfolio income$216,122 $189,960 $627,468 $562,492 
Changes in expected recoveries60,614 22,156 185,608 6,380 
Total portfolio revenue276,736 212,116 813,076 568,872 
Other revenue4,741 4,314 8,216 12,264 
Total revenues281,477 216,430 821,292 581,136 
Operating expenses:
Compensation and employee services76,106 69,517 223,944 217,708 
Legal collection fees14,479 9,839 40,353 28,228 
Legal collection costs28,781 20,761 90,746 66,228 
Agency fees21,020 19,436 61,751 54,491 
Outside fees and services20,452 18,858 63,626 62,064 
Communication10,048 9,881 34,203 30,525 
Rent and occupancy4,175 4,426 12,455 13,193 
Depreciation and amortization2,469 3,273 7,826 10,344 
Impairment of real estate 5,037  5,037 
Other operating expenses13,969 12,356 40,792 38,355 
Total operating expenses191,499 173,384 575,696 526,173 
    Income from operations89,978 43,046 245,596 54,963 
Other income and (expense):
Interest expense, net(61,062)(49,473)(168,693)(130,778)
Foreign exchange gain, net10 564 138 984 
Other(676)(500)(836)(1,380)
Income/(loss) before income taxes28,250 (6,363)76,205 (76,211)
Income tax expense/(benefit)(672)1,788 10,416 (15,317)
Net income/(loss)28,922 (8,151)65,789 (60,894)
Adjustment for net income attributable to noncontrolling interests1,768 4,111 13,644 13,801 
Net income/(loss) attributable to PRA Group, Inc.$27,154 $(12,262)$52,145 $(74,695)
Net income/(loss) per common share attributable to PRA Group, Inc.:
Basic$0.69 $(0.31)$1.33 $(1.91)
Diluted$0.69 $(0.31)$1.32 $(1.91)
Weighted average number of shares outstanding:
Basic39,421 39,242 39,353 39,155 
Diluted39,492 39,242 39,495 39,155 
The accompanying notes are an integral part of these Consolidated Financial Statements.
4


PRA Group, Inc.
Consolidated Statements of Comprehensive Income
For the Three and Nine Months Ended September 30, 2024 and 2023
(Amounts in thousands)
(unaudited)

Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Net income/(loss)$28,922 $(8,151)$65,789 $(60,894)
Other comprehensive income/(loss), net of tax
Foreign currency translation adjustments52,979 (34,279)(9,470)(28,746)
Cash flow hedges(8,503)(7,660)(6,988)(6,772)
Debt securities available-for-sale246 (26)357 22 
Other comprehensive income/(loss)44,722 (41,965)(16,101)(35,496)
Total comprehensive income/(loss)73,644 (50,116)49,688 (96,390)
Less comprehensive income attributable to noncontrolling interests3,301 1,436 6,263 17,668 
Comprehensive income/(loss) attributable to PRA Group, Inc.$70,343 $(51,552)$43,425 $(114,058)
The accompanying notes are an integral part of these Consolidated Financial Statements.
5


PRA Group, Inc.
Consolidated Statements of Changes in Equity
For the Nine Months Ended September 30, 2024
(Amounts in thousands)
(unaudited)

Common StockAdditional Paid-InRetainedAccumulated Other ComprehensiveNoncontrollingTotal
SharesAmountCapitalEarningsIncome/(Loss)InterestsEquity
Balance as of December 31, 202339,247 $392 $7,071 $1,489,548 $(329,899)$72,264 $1,239,376 
Components of comprehensive income, net of tax:
Net income— — — 3,475 — 8,278 11,753 
Foreign currency translation adjustments— — — — (45,973)(2,218)(48,191)
Cash flow hedges— — — — 2,808 — 2,808 
Debt securities available-for-sale— — — — 46 — 46 
Distributions to noncontrolling interests— — — — — (11,332)(11,332)
Vesting of restricted stock98 1 (1)— — — — 
Share-based compensation expense— — 3,327 — — — 3,327 
Employee stock relinquished for payment of taxes— — (1,469)— — — (1,469)
Balance as of March 31, 202439,345 $393 $8,928 $1,493,023 $(373,018)$66,992 $1,196,318 
Components of comprehensive income, net of tax:
Net income— — — 21,516 — 3,598 25,114 
Foreign currency translation adjustments— — — — (7,563)(6,695)(14,258)
Cash flow hedges— — — — (1,293)— (1,293)
Debt securities available-for-sale— — — — 65 — 65 
Distributions to noncontrolling interests— — — — — (6,080)(6,080)
Vesting of restricted stock72 1 (1)— — — — 
Share-based compensation expense— — 3,555 — — — 3,555 
Employee stock relinquished for payment of taxes— — (143)— — — (143)
Balance as of June 30, 202439,417 $394 $12,339 $1,514,539 $(381,809)$57,815 $1,203,278 
Components of comprehensive income, net of tax:
Net income— — — 27,154 — 1,768 28,922 
Foreign currency translation adjustments— — — — 51,446 1,533 52,979 
Cash flow hedges— — — — (8,503)— (8,503)
Debt securities available-for-sale— — — — 246 — 246 
Distributions to noncontrolling interests— — — — — (602)(602)
Contributions from noncontrolling interests— — — — — 2,396 2,396 
Vesting of restricted stock9   — — — — 
Share-based compensation expense— — 3,251 — — — 3,251 
Employee stock relinquished for payment of taxes— — (175)— — — (175)
Balance as of September 30, 202439,426 $394 $15,415 $1,541,693 $(338,620)$62,910 $1,281,792 

The accompanying notes are an integral part of these Consolidated Financial Statements.













6


PRA Group, Inc.
Consolidated Statements of Changes in Equity
For the Nine Months Ended September 30, 2023
(Amounts in thousands)
(unaudited)

Common StockAdditional Paid-InRetainedAccumulated Other ComprehensiveNoncontrollingTotal
SharesAmountCapitalEarningsIncome/(Loss)InterestsEquity
Balance as of December 31, 202238,980 $390 $2,172 $1,573,025 $(347,926)$59,089 $1,286,750 
Components of comprehensive income, net of tax:
Net income/(loss)— — — (58,629)— 4,726 (53,903)
Foreign currency translation adjustments— — — — (4,101)2,551 (1,550)
Cash flow hedges— — — — (4,831)— (4,831)
Debt securities available-for-sale— — — — 128 — 128 
Vesting of restricted stock190 2 (2)— — — — 
Share-based compensation expense— — 3,799 — — — 3,799 
Employee stock relinquished for payment of taxes— — (5,684)— — — (5,684)
Balance as of March 31, 202339,170 $392 $285 $1,514,396 $(356,730)$66,366 $1,224,709 
Components of comprehensive income, net of tax:
Net income/(loss)— — — (3,804)— 4,964 1,160 
Foreign currency translation adjustments— — — — 3,091 3,992 7,083 
Cash flow hedges— — — — 5,719 — 5,719 
Debt securities available-for-sale— — — — (80)— (80)
Distributions to noncontrolling interests— — — — — (1,173)(1,173)
Vesting of restricted stock72   — — — — 
Share-based compensation expense— — 2,715 — — — 2,715 
Employee stock relinquished for payment of taxes— — (459)— — — (459)
Balance as of June 30, 202339,242 $392 $2,541 $1,510,592 $(348,000)$74,149 $1,239,674 
Components of comprehensive income, net of tax:
Net income/(loss)— — — (12,262)— 4,111 (8,151)
Foreign currency translation adjustments— — — — (31,603)(2,676)(34,279)
Cash flow hedges— — — — (7,660)— (7,660)
Debt securities available-for-sale— — — — (26)— (26)
Distributions to noncontrolling interests— — — — — (1,187)(1,187)
Vesting of restricted stock1   — — — — 
Share-based compensation expense— — 1,629 — — — 1,629 
Employee stock relinquished for payment of taxes— — (13)— — — (13)
Balance as of September 30, 202339,243 $392 $4,157 $1,498,330 $(387,289)$74,397 $1,189,987 

The accompanying notes are an integral part of these Consolidated Financial Statements.
7


PRA Group, Inc.
Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2024
(Amounts in thousands)
(unaudited)

Nine Months Ended September 30,
20242023
Cash flows from operating activities:
Net income/(loss)$65,789 $(60,894)
Adjustments to reconcile net income/(loss) to net cash used in operating activities:
Share-based compensation10,133 8,143 
Depreciation, amortization and impairment7,826 15,381 
Amortization of debt discount and issuance costs8,326 7,045 
Changes in expected recoveries(185,608)(6,380)
Deferred income taxes(7,277)(26,276)
Net unrealized foreign currency transaction gain(16,593)(31,783)
Other(234)(567)
Changes in operating assets and liabilities:
Other assets(201)1,111 
Accrued expenses, accounts payable and other liabilities(22,092)(5,793)
Income taxes payable, net2,407 (18,259)
Net cash used in operating activities(137,524)(118,272)
Cash flows from investing activities:
Purchases of property and equipment, net(2,881)(2,306)
Purchases of nonperforming loan portfolios(975,164)(875,373)
Recoveries applied to negative allowance784,329 695,386 
Purchases of investments(48,247)(60,058)
Proceeds from sales and maturities of investments58,130 62,762 
Net cash used in investing activities(183,833)(179,589)
Cash flows from financing activities:
Proceeds from lines of credit958,636 695,651 
Principal payments on lines of credit(693,622)(389,658)
Principal payments on long-term debt(10,000)(7,500)
Proceeds from issuance of Senior Notes due 2030400,000  
Proceeds from issuance of Senior Notes due 2028 400,000 
Retirement of Senior Notes due 2025(298,000) 
Retirement of Convertible Senior Notes due 2023 (345,000)
Repurchases of senior notes (3,657)
Payments of origination costs and fees(5,926)(5,323)
Tax withholdings related to share-based payments(1,787)(6,155)
Distributions to noncontrolling interests(18,014)(2,360)
Contributions from noncontrolling interests2,396  
Net increase/(decrease) in interest-bearing deposits13,390 (7,747)
Net cash provided by financing activities347,073 328,251 
Effect of exchange rates on cash3,024 3,270 
Net increase in cash, cash equivalents and restricted cash28,740 33,660 
Cash, cash equivalents and restricted cash, beginning of period113,692 84,758 
Cash, cash equivalents and restricted cash, end of period$142,432 $118,418 
Supplemental disclosure of cash flow information:
Cash paid for interest$176,537 $111,344 
Cash paid for income taxes15,460 28,479 
Reconciliation to Balance Sheet accounts:
Cash and cash equivalents$141,135 $105,172 
Restricted cash included in Other assets1,297 13,246 
Cash, cash equivalents and restricted cash$142,432 $118,418 

The accompanying notes are an integral part of these Consolidated Financial Statements.
8

PRA Group, Inc.
Notes to Consolidated Financial Statements

1. Organization and Business:
Nature of operations: As used herein, the terms "PRA Group," the "Company," or similar terms refer to PRA Group, Inc. and its subsidiaries.
PRA Group, Inc., a Delaware corporation, is a global financial and business services company with operations in the Americas, Europe and Australia. The Company's primary business is the purchase, collection and management of portfolios of nonperforming loans. The Company also provides fee-based services on class action claims recoveries in the United States ("U.S.").
Basis of presentation: The Consolidated Financial Statements of the Company are prepared in accordance with U.S. generally accepted accounting principles ("GAAP"). The accompanying interim financial statements have been prepared in accordance with the instructions for Quarterly Reports on Form 10-Q, and therefore, do not include all information and Notes to the Consolidated Financial Statements necessary for a complete presentation of financial position, results of operations, comprehensive income/(loss) and cash flows in conformity with GAAP. In the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair presentation of the Company's Consolidated Balance Sheets as of September 30, 2024, its Consolidated Income Statements and Statements of Comprehensive Income for the three and nine months ended September 30, 2024 and 2023, and its Consolidated Statements of Changes in Equity and Statements of Cash Flows for the nine months ended September 30, 2024 and 2023, have been included. The Consolidated Financial Statements include the accounts of PRA Group and other entities in which the Company has a controlling interest. All significant intercompany accounts and transactions have been eliminated.
These unaudited Consolidated Financial Statements should be read in conjunction with the audited Consolidated Financial Statements and notes thereto included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 (the "2023 Form 10-K"). For further discussion of the Company's significant accounting policies, refer to Note 1 to the Consolidated Financial Statements in the 2023 Form 10-K. There were no material changes to these policies during the three months ended September 30, 2024.
The preparation of the Consolidated Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect reported amounts and disclosures. Realized results could differ from those estimates and assumptions, and the Company's Consolidated Income Statements for the three and nine months ended September 30, 2024 may not be indicative of future results.
Reclassification of prior year presentation: In the Consolidated Statements of Cash Flows, certain prior period amounts have been reclassified for consistency with the current period presentation.
2. Finance Receivables, net:
Finance receivables, net consisted of the following as of September 30, 2024 and December 31, 2023 (amounts in thousands):
September 30, 2024December 31, 2023
Amortized cost$ $ 
Negative allowance for expected recoveries4,064,467 3,656,598 
Balance at end of period$4,064,467 $3,656,598 







9

PRA Group, Inc.
Notes to Consolidated Financial Statements
Changes in the negative allowance for expected recoveries by portfolio segment for the three and nine months ended September 30, 2024 and 2023 were as follows (amounts in thousands):
Three Months Ended September 30,
20242023
CoreInsolvencyTotalCoreInsolvencyTotal
Balance at beginning of period$3,450,721 $369,465 $3,820,186 $3,086,405 $338,143 $3,424,548 
Initial negative allowance for expected recoveries - portfolio acquisitions (1)
335,120 14,858 349,978 248,181 63,002 311,183 
Recoveries applied to negative allowance (2)
(222,960)(40,429)(263,389)(189,710)(41,709)(231,419)
Changes in expected recoveries (3)
55,992 4,622 60,614 15,894 6,262 22,156 
Foreign currency translation adjustment$87,496 $9,582 $97,078 $(58,878)$(6,786)$(65,664)
Balance at end of period$3,706,369 $358,098 $4,064,467 $3,101,892 $358,912 $3,460,804 
Nine Months Ended September 30,
20242023
CoreInsolvencyTotalCoreInsolvencyTotal
Balance at beginning of period$3,295,214 $361,384 $3,656,598 $2,936,207 $358,801 $3,295,008 
Initial negative allowance for expected recoveries - portfolio acquisitions (1)
880,529 94,635 975,164 763,776 105,391 869,167 
Recoveries applied to negative allowance (2)
(664,423)(119,906)(784,329)(574,993)(120,392)(695,385)
Changes in expected recoveries (3)
171,303 14,305 185,608 (7,436)13,816 6,380 
Foreign currency translation adjustment$23,746 $7,680 $31,426 $(15,662)$1,296 $(14,366)
Balance at end of period$3,706,369 $358,098 $4,064,467 $3,101,892 $358,912 $3,460,804 
(1) Initial negative allowance for expected recoveries - portfolio acquisitions
Portfolio acquisitions for the three and nine months ended September 30, 2024 and 2023 were as follows (amounts in thousands):
Three Months Ended September 30,
20242023
CoreInsolvencyTotalCoreInsolvencyTotal
Face value$3,739,494 $75,859 $3,815,353 $1,992,448 $382,363 $2,374,811 
Noncredit discount(333,122)(7,837)(340,959)(209,131)(23,837)(232,968)
Allowance for credit losses at acquisition(3,071,252)(53,164)(3,124,416)(1,535,136)(295,524)(1,830,660)
Purchase price$335,120 $14,858 $349,978 $248,181 $63,002 $311,183 
Nine Months Ended September 30,
20242023
CoreInsolvencyTotalCoreInsolvencyTotal
Face value$7,850,273 $469,492 $8,319,765 $5,717,674 $579,113 $6,296,787 
Noncredit discount(881,441)(44,465)(925,906)(600,174)(38,621)(638,795)
Allowance for credit losses at acquisition(6,088,303)(330,392)(6,418,695)(4,353,724)(435,101)(4,788,825)
Purchase price$880,529 $94,635 $975,164 $763,776 $105,391 $869,167 




10

PRA Group, Inc.
Notes to Consolidated Financial Statements
The initial negative allowance recorded on portfolio acquisitions for the three and nine months ended September 30, 2024 and 2023 was as follows (amounts in thousands):
Three Months Ended September 30,
20242023
CoreInsolvencyTotalCoreInsolvencyTotal
Allowance for credit losses at acquisition$(3,071,252)$(53,164)$(3,124,416)$(1,535,136)$(295,524)$(1,830,660)
Writeoffs, net3,071,252 53,164 3,124,416 1,535,136 295,524 1,830,660 
Expected recoveries335,120 14,858 349,978 248,181 63,002 311,183 
Initial negative allowance for expected recoveries$335,120 $14,858 $349,978 $248,181 $63,002 $311,183 
Nine Months Ended September 30,
20242023
CoreInsolvencyTotalCoreInsolvencyTotal
Allowance for credit losses at acquisition$(6,088,303)$(330,392)$(6,418,695)$(4,353,724)$(435,101)$(4,788,825)
Writeoffs, net6,088,303 330,392 6,418,695 4,353,724 435,101 4,788,825 
Expected recoveries880,529 94,635 975,164 763,776 105,391 869,167 
Initial negative allowance for expected recoveries$880,529 $94,635 $975,164 $763,776 $105,391 $869,167 
(2) Recoveries applied to negative allowance
Recoveries applied to the negative allowance for the three and nine months ended September 30, 2024 and 2023 were as follows (amounts in thousands):
Three Months Ended September 30,
20242023
CoreInsolvencyTotalCoreInsolvencyTotal
Recoveries (a)
$426,574 $52,937 $479,511 $369,385 $51,994 $421,379 
Less - amounts reclassified to portfolio income203,614 12,508 216,122 179,675 10,285 189,960 
Recoveries applied to negative allowance$222,960 $40,429 $263,389 $189,710 $41,709 $231,419 
Nine Months Ended September 30,
20242023
CoreInsolvencyTotalCoreInsolvencyTotal
Recoveries (a)
$1,256,546 $155,251 $1,411,797 $1,106,799 $151,078 $1,257,877 
Less - amounts reclassified to portfolio income 592,123 35,345 627,468 531,806 30,686 562,492 
Recoveries applied to negative allowance$664,423 $119,906 $784,329 $574,993 $120,392 $695,385 
(a) Recoveries include cash collections, buybacks and other cash-based adjustments.
(3) Changes in expected recoveries
The Company develops its estimates of expected recoveries by applying discounted cash flow methodologies to its estimated remaining collections and recognizes income over the estimated life of the pool at the constant effective interest rate of the pool. For additional information about these methodologies, refer to Note 1 to the Consolidated Financial Statements in the 2023 Form 10-K.




11

PRA Group, Inc.
Notes to Consolidated Financial Statements
Changes in expected recoveries for the three months ended September 30, 2024 and 2023 were as follows (amounts in thousands):
Three Months Ended September 30,
20242023
CoreInsolvencyTotalCoreInsolvencyTotal
Recoveries received in excess of forecast$29,133 $5,025 $34,158 $11,660 $6,430 $18,090 
Changes in expected future recoveries 26,859 (403)26,456 4,234 (168)4,066 
Changes in expected recoveries$55,992 $4,622 $60,614 $15,894 $6,262 $22,156 
Changes in expected recoveries for the three months ended September 30, 2024 were $60.6 million, which included $34.2 million in recoveries received in excess of forecast (cash collections overperformance), due primarily to collections performance in the U.S. and Europe. Changes in expected future recoveries of $26.5 million mainly reflect the Company's assessment of the 2013 to 2020 U.S. Core pools and a number of pools in Europe, which resulted in increases to the expected cash flows considering that recent performance of those pools is expected to continue.
Changes in expected recoveries for the three months ended September 30, 2023 were a net positive $22.2 million. This included $18.1 million in recoveries received in excess of forecast (cash collections overperformance) and a $4.1 million positive adjustment to changes in expected future recoveries. The $18.1 million in recoveries received in excess of forecast reflected overperformance in Europe and the Americas.
Changes in expected recoveries for the nine months ended September 30, 2024 and 2023 were as follows (amounts in thousands):
Nine Months Ended September 30,
20242023
CoreInsolvencyTotalCoreInsolvencyTotal
Recoveries received in excess of forecast$109,881 $14,375 $124,256 $33,483 $13,793 $47,276 
Changes in expected future recoveries 61,422 (70)61,352 (40,919)23 (40,896)
Changes in expected recoveries$171,303 $14,305 $185,608 $(7,436)$13,816 $6,380 
Changes in expected recoveries for the nine months ended September 30, 2024 were $185.6 million, which included $124.3 million in recoveries received in excess of forecast, due primarily to collections performance in the U.S. and Europe. Changes in expected future recoveries of $61.4 million mainly reflect the Company's assessment of the 2013 to 2020 U.S. Core pools and a number of pools in Europe, which resulted in increases to the expected cash flows considering that recent performance of those pools is expected to continue.
Changes in expected recoveries for the nine months ended September 30, 2023 were a net positive $6.4 million. This included $47.3 million in recoveries received in excess of forecast (cash collections overperformance), primarily due to continued strong performance in Europe and South America, and a $40.9 million negative adjustment to changes in expected future recoveries. The changes in expected future recoveries reflected the Company's assessment of certain pools, which resulted in a reduction of expected cash flows due largely to collections performance in the U.S.
3. Investments:
Investments consisted of the following as of September 30, 2024 and December 31, 2023 (amounts in thousands):
September 30, 2024December 31, 2023
Debt securities
Available-for-sale$50,605 $59,470 
Equity securities
Private equity funds1,831 2,451 
Equity method investment8,886 10,483 
Total investments$61,322 $72,404 
Debt Securities
12

PRA Group, Inc.
Notes to Consolidated Financial Statements
Government securities: As of September 30, 2024, the Company's available-for-sale debt securities consisted of Swedish treasury securities maturing within one year. As of September 30, 2024 and December 31, 2023, the amortized cost and fair value of these investments were as follows (amounts in thousands):
September 30, 2024
Amortized CostGross Unrealized GainsAggregate Fair Value
Available-for-sale
Government securities$50,293 $312 $50,605 
December 31, 2023
Amortized CostGross Unrealized GainsAggregate Fair Value
Available-for-sale
Government securities$59,404 $66 $59,470 
Equity Method Investment
The Company has an 11.7% interest in RCB Investimentos S.A. ("RCB"), a servicing platform for nonperforming loans in Brazil, accounted for under the equity method.
4. Goodwill:
The Company performs an annual review of goodwill as of October 1 of each year, or more frequently if indicators of impairment exist, with the most recent annual review performed as of October 1, 2023. The Company performed a quarterly assessment by evaluating whether any triggering events had occurred as of September 30, 2024, which included considering current market conditions, and determined that goodwill was not more-likely-than-not impaired. Changes in goodwill for the three and nine months ended September 30, 2024 and 2023, were as follows (amounts in thousands):
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Balance as of beginning of period$415,646 $414,905 $431,564 $435,921 
Foreign currency translation7,365 (2,392)(8,553)(23,408)
Balance as of end of period$423,011 $412,513 $423,011 $412,513 

13

PRA Group, Inc.
Notes to Consolidated Financial Statements
5. Borrowings:
Borrowings consisted of the following as of September 30, 2024 and December 31, 2023 (amounts in thousands):
September 30, 2024December 31, 2023
North American revolving credit facility (1)
$683,890 $396,303 
United Kingdom revolving credit facility (2)
508,060 502,847 
European revolving credit facility (3)
537,172 538,565 
North American term loan (4)
432,500 442,500 
Credit facility borrowings2,161,622 1,880,215 
Senior Notes due 2025 (the "2025 Notes") 298,000 
Senior Notes due 2028 (the "2028 Notes")398,000 398,000 
Senior Notes due 2029 (the "2029 Notes")350,000 350,000 
Senior Notes due 2030 (the "2030 Notes")400,000  
Senior notes1,148,000 1,046,000 
Credit facility borrowings and senior notes3,309,622 2,926,215 
Debt discount and issuance costs(13,450)(11,945)
Borrowings$3,296,172 $2,914,270 
(1)Revolving credit facility under the Company's North American Revolving Credit and Term Loan (the "North American Credit Agreement"), which included an aggregate principal amount of $1.5 billion (subject to compliance with a borrowing base and applicable debt covenants), consisting of (i) a fully-funded $432.5 million term loan (the "Term Loan"), (ii) a $1.0 billion domestic revolving credit facility, and (iii) a $75.0 million Canadian revolving credit facility, maturing on July 30, 2026. The North American Credit Agreement was amended and extended on October 28, 2024 (refer to Note 13 for additional details).
(2)Revolving credit facility under the Company's United Kingdom ("UK") Credit Agreement (the "UK Credit Agreement"), which consisted of an $800.0 million revolving credit facility (subject to a borrowing base) and an accordion feature for up to $200.0 million in additional commitments, subject to certain conditions, maturing on July 30, 2026. The UK Credit Agreement was amended and extended on October 30, 2024 (refer to Note 13 for additional details).
(3)Revolving credit facility under the Company's European Credit Agreement (the "European Credit Agreement"), providing revolving borrowings for an aggregate amount of approximately €730.0 million (subject to the borrowing base and applicable debt covenants) and an accordion feature for up to €500.0 million, subject to certain conditions, maturing on November 23, 2027. As of September 30, 2024, after an increase in limit during the quarter ended March 31, 2024, interest bearing deposits in AK Nordic AB cannot exceed SEK2.2 billion. The European Credit Agreement was amended on October 28, 2024 (refer to Note 13 for additional details).
(4)Term Loan under the North American Credit Agreement.
During the quarter ended June 30, 2024, the Company repaid $395.9 million aggregate principal amount of outstanding borrowings under the North American revolving credit facility with net proceeds obtained from issuance of the 2030 Notes. On September 3, 2024, using funds obtained primarily from the North American revolving credit facility, the Company repaid the 2025 Notes in full by redeeming $298.0 million in aggregate principal amount of the 2025 Notes at par value.
For additional details about the North American Credit Agreement, UK Credit Agreement, European Credit Agreement and the Company's senior notes, refer to Note 7 to the Consolidated Financial Statements in the 2023 Form 10-K and description of the 2030 Notes below.
The Company was in compliance with the covenants contained in its financing arrangements as of September 30, 2024.
2030 Notes
On May 20, 2024, the Company completed the private offering of $400.0 million in aggregate principal amount of its 8.875% Senior Notes due January 31, 2030. The 2030 Notes were issued pursuant to an Indenture dated May 20, 2024 (the "2024 Indenture"), between the Company and Regions Bank, as trustee. The 2024 Indenture contains customary terms and covenants, including certain events of default after which the 2030 Notes may be due and payable immediately. The 2030 Notes are senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by all of the Company's existing and future domestic restricted subsidiaries that guarantee the North American Credit Agreement, subject to certain exceptions. Interest on the 2030 Notes is payable semi-annually, in arrears, on January 31 and July 31 of each year.
Before June 1, 2026, the Company may redeem the 2030 Notes, in whole or in part, at a price equal to 100% of the aggregate principal amount of the 2030 Notes being redeemed, plus the applicable "make whole" premium. On or before June 1, 2026, the Company may redeem up to 40% of the aggregate principal amount of the 2030 Notes at a redemption price of 108.875% plus accrued and unpaid interest with the net cash proceeds of a public offering of common stock of the Company
14

PRA Group, Inc.
Notes to Consolidated Financial Statements
provided, that at least 60% in aggregate principal amount of the 2030 Notes remains outstanding immediately after the occurrence of such redemption and that such redemption will occur within 90 days of the date of the closing of such public offering.
In addition, on or after June 1, 2026, the Company may redeem the 2030 Notes, in whole or in part, at a price equal to 104.438% of the aggregate principal amount of the 2030 Notes being redeemed. The applicable redemption price changes if redeemed during the 12 months beginning June 1 of each year to 102.219% for 2027 and then 100% for 2028 and thereafter.
In the event of a change of control, each holder will have the right to require the Company to repurchase all or any part of such holder's 2030 Notes at an offer price equal to 101% of the aggregate principal amount plus accrued and unpaid interest. If the Company sells assets under certain circumstances and does not use the proceeds for specified purposes, the Company will be required to make an offer to repurchase the 2030 Notes at 100% of their principal amount plus accrued and unpaid interest.
6. Derivatives:
The Company periodically enters into derivative financial instruments; typically interest rate swaps and foreign currency contracts, to reduce its exposure to fluctuations in interest rates on variable-rate debt and foreign currency exchange rates. Derivative financial instruments are recognized at fair value in the Company's Consolidated Balance Sheets. For further discussion of the Company's use of derivative instruments, refer to Note 8 to the Consolidated Financial Statements in the 2023 Form 10-K. The following table summarizes the fair value of derivative financial instruments as of September 30, 2024 and December 31, 2023 (amounts in thousands):
September 30, 2024December 31, 2023
Balance Sheet AccountFair ValueBalance Sheet AccountFair Value
Derivatives designated as hedging instruments:
Interest rate contractsOther assets$9,856 Other assets$21,770 
Interest rate contractsOther liabilities8,956 Other liabilities11,627 
Derivatives not designated as hedging instruments:
Foreign currency contractsOther assets923 Other assets1,007 
Foreign currency contractsOther liabilities345 Other liabilities8,776 
Derivatives Designated as Hedging Instruments:
Changes in the fair value of derivative contracts designated as cash flow hedging instruments are recognized in other comprehensive income ("OCI"). As of September 30, 2024 and December 31, 2023, the notional amount of interest rate contracts designated as cash flow hedging instruments was $827.9 million and $872.3 million, respectively. Derivatives designated as cash flow hedging instruments remained highly effective as of September 30, 2024, and have remaining terms from three months to four years. As of September 30, 2024, the Company estimates that $5.7 million of net derivative gains included in OCI will be reclassified into earnings within the next 12 months.
The following tables summarize the effects of derivatives designated as cash flow hedging instruments for the three and nine months ended September 30, 2024 and 2023 (amounts in thousands):
Gain/(loss) recognized in OCI, net of tax
Three Months Ended September 30,Nine Months Ended September 30,
Hedging instrument2024202320242023
Interest rate contracts$(4,321)$(2,712)$5,609 $7,430 
Gain reclassified from OCI into income
Three Months Ended September 30,